metformin vs glp 1 for pcos The dual impact of GLP-1 receptor agonists on metabolic and reproductive health in polycystic ovary syndrome: insights from human and animal trials Ozempic for PCOS: Weight Loss,

In clinical trials, patients lost 12 percent of their body weight on average, in line with the original Ozempic injection, but a smidge lower than Mounjaro, Zepbound, and some of the more recent entries into this drug class

Conflict of Interest Statement S.L.B

Although Glp1r expression is mostly localized to endothelial cells in the mouse aorta (29), other vascular cell types may express Glp1r under atherogenic conditions, making it difficult to pinpoint which cell type mediates the antiinflammatory effects of GLP-1 medicines

M.CarrR

Therefore, clinicians must set realistic expectations when initiating GLP-1based adjunct treatment in type 1 diabetes

The risk of hypoglycemia is generally higher with Ozempic compared to metformin